Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Intelligent Bio Solutions (INBS) Preferred Shares Issued (2020)

Intelligent Bio Solutions has reported Preferred Shares Issued over the past 1 years, most recently at $3.3 million for Q3 2020.

For Q3 2020, Preferred Shares Issued changed N/A year-over-year to $3.3 million; the TTM value through Jun 2021 reached $3.3 million, changed N/A, while the annual FY2023 figure was $220578.0, N/A changed from the prior year.
Preferred Shares Issued for Q3 2020 was $3.3 million at Intelligent Bio Solutions, up from $352500.0 in the prior quarter.
Over five years, Preferred Shares Issued peaked at $3.3 million in Q3 2020 and troughed at $352500.0 in Q2 2020.